Riskpilot← Back to searchSign inGet full accessHH-Syklus Oy
OYActiveY-tunnus 0777358-3Pikinoukka 4Medical specialists activities · NACE 8622Est. 1989— employees
Revenue 2025
EUR 269K
+12% vs 2024
EBITDA margin
32.5%
-29% vs 2024
Equity ratio
98.8%
Financial strength
Net profit 2025
EUR 44K
-33% vs 2024
| Revenue | EUR 269K | +12% |
| EBITDA | EUR 87K | -29% |
| Net profit | EUR 44K | -33% |
| Total assets | EUR 443K | +1% |
| Equity | EUR 437K | +2% |
| Employees | — | — |
Legal name
HH-Syklus Oy
Y-tunnus number
0777358-3
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
28. kesäkuuta 1989
Share capital
EUR 8 914
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-07-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimialana on vastaanottotoiminta, röntgen-, laboratorio- ja ultraäänitutkimuspalvelujen tuottaminen, histologisten ja sytologisten näytteiden tutkiminen lausuntoineen, terveyshuolto, kotisairaanhoito, laitoskonsultointi, lääkintäalan tuotesuunnittelu ja -kehittely sekä osakkeiden, arvopapereiden, kiinteistöjen ja asunto-osakkeiden osto-, myynti- ja vuokraustoiminta.
Address
Pikinoukka 4
Phone
+3580405137228
Email
juha.hagman@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 255 | 239 | 244 | 239 | 269 |
| Staff expenses | −61 | −81 | −73 | −53 | −78 |
| EBITDA | 78 | 79 | 86 | 123 | 87 |
| Depreciation & amort. | −0 | −0 | −16 | −42 | −32 |
| EBIT | 78 | 79 | 69 | 80 | 55 |
| Net financials | 2 | 1 | 10 | 3 | −0 |
| Profit before tax | 80 | 80 | 80 | 83 | 55 |
| Tax | 16 | 16 | −0 | 17 | 11 |
| Net profit | 64 | 64 | 64 | 66 | 44 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 516 | 516 | 467 | 440 | 443 |
| Equity | 498 | 493 | 460 | 428 | 437 |
| Long-term debt | — | — | 0 | 0 | 0 |
| Short-term debt | 17 | 23 | 746 | 13 | 5 |
| Total debt | 17 | 23 | 7 | 13 | 5 |
EBITDA margin
32.5%
This company
15.8%
Market median
+106% vs market
20212025
Equity ratio
98.8%
This company
38.2%
Market median
+159% vs market
20212025
Return on equity
10.0%
This company
18.4%
Market median
-46% vs market
20212025
Net profit margin
16.3%
This company
8.1%
Market median
+101% vs market
20212025
Asset turnover
0.61×
This company
1.12×
Market median
-46% vs market
20212025
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2024-08-01 – 2025-07-31
- Annual report 2024Filed via PRH / YTJ · Period 2023-08-01 – 2024-07-31
- Annual report 2023Filed via PRH / YTJ · Period 2022-08-01 – 2023-07-31
- Annual report 2022Filed via PRH / YTJ · Period 2021-08-01 – 2022-07-31
- Annual report 2021Filed via PRH / YTJ · Period 2020-08-01 – 2021-07-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JS Chief Executive Officer | Chief Executive Officer | 2018 |
| Former (2) | ||
OJ | Audit | 2020 – 2023 |
TK Audit | Audit | 2018 – 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2012 | |
| Chairperson | 2020 | |
| Board of Directors | 2022 | |
| Former (2) | ||
| Board of Directors | 2020 – 2022 | |
| Board of Directors | 2012 – 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of HH-Syklus Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Olli Johannes Penttilä | Audit | 0 companies |
| Tatu Kalevi Huhtala | Audit | 0 companies |
| Juha Samuli Hagman | Chief Executive Officer | 0 companies |
| Matti Kalevi Heikkilä | Board of Directors | 0 companies |
| Anna-Sofia Arponen | Chairperson | 0 companies |
| Juuso Tuomas Arponen | Board of Directors | 0 companies |
| Eelis Eemil Hagman | Board of Directors | 0 companies |
| Seppo Antero Varpuluoma | Board of Directors | 0 companies |